D
David Eisenberg
Researcher at Technion – Israel Institute of Technology
Publications - 719
Citations - 120468
David Eisenberg is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Amyloid & Protein structure. The author has an hindex of 156, co-authored 697 publications receiving 112460 citations. Previous affiliations of David Eisenberg include Howard Hughes Medical Institute & Hebrew University of Jerusalem.
Papers
More filters
Posted ContentDOI
Amyloid fibrils in frontotemporal lobar degeneration with TDP-43 inclusions are composed of TMEM106B, rather than TDP-43
Y. Jiang,Qin Cao,Michael R. Sawaya,Romany Abskharon,Peng Ge,Michael DeTure,Dennis W. Dickson,Janine Fu,Rachel R. Ogorzalek Loo,Joseph A. Loo,David Eisenberg +10 more
TL;DR: It is suggested that amyloid involvement in FTLD-TDP is of protein TMEM106B, rather than of TDP-43, as revealed by immunogold labeling.
Journal ArticleDOI
What Competencies Should Medical Students Attain in Nutritional Medicine
Victor S. Sierpina,Karen Welch,Stephen Devries,David Eisenberg,Lyuba Levine,Juliet M. McKee,Mauli Dalal,Paul Mendoza,Jean Gutierrez,Robertson S,Drusilla Rosales +10 more
Book ChapterDOI
Electron microscopy of glutamine synthetase dna interactions
TL;DR: Electron micrographs now show that glutamine synthetase binds to DNA, and the affinity is non-specific: GS1 binds to phage DNA containing an operon that GS is known to regulate, but also to wild type phageDNA, and to DNAs as diverse as colicine ElI and calf thymus.
Posted ContentDOI
CRISPR screens in iPSC-derived neurons reveal principles of tau proteostasis
Avi J. Samelson,Justin McKetney,Ruilin Tian,Parker Grosjean,Romany Abskharon,David Eisenberg,Nicholas M. Kanaan,Li Gan,Carlo Condello,Danielle L. Swaney,Martin Kampmann +10 more
TL;DR: In this article , a genome-wide CRISPRi-based modifier screen was conducted in iPSC-derived neurons to uncover the cellular factors controlling the accumulation of tau aggregates in human neurons.